Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 2 boards, counting each seat separately. Longest: Neumora Therapeutics Inc., 3 years.
Neumora Therapeutics Inc.
Director · See Remarks
Kardigan Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Neumora Therapeutics Inc. May 27, 202695.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Kardigan Inc. | Open-market purchase | +1,250,000 | $16.00 | $20,000,000 |
| Jun 17, 2026 | Kardigan Inc. | Derivative conversion | +13,792,035 | — | — |
| Jun 17, 2026 | Kardigan Inc. | Grant or award | +20,706 | — | — |
| Mar 6, 2026 | Lyell Immunopharma Inc. | Open-market purchase | +488,090 | $25.61 | $12,499,985 |
| Feb 17, 2026 | Neumora Therapeutics Inc. | Open-market sale | −9,819 | $3.51 | $34,465 |
| Feb 18, 2025 | Neumora Therapeutics Inc. | Open-market sale | −13,871 | $1.69 | $23,442 |
| Dec 27, 2024 | Neumora Therapeutics Inc. | Gift | −133,097 | — | — |
| Dec 27, 2024 | Neumora Therapeutics Inc. | Gift | −133,097 | — | — |
| Dec 27, 2024 | Neumora Therapeutics Inc. | Gift | −133,097 | — | — |
| Feb 14, 2024 | Neumora Therapeutics Inc. | Grant or award | +171,250 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.